Healthcare enters 2026 with a mixed setup. Large-cap pharma and managed care provide cash flow stability, while biotech depends on funding conditions, catalysts, and M&A appetite.
Sector AnalysisETF: XLVUpdated Jul 8, 2026
Healthcare Sector Stocks: Performance, Valuations & Industry Comps
Driven by GLP-1 growth leaders like Eli Lilly, healthcare trades at a 19x Forward P/E. This dashboard tracks valuation trends, equal-weight performance, and sector component data across all 900+ pharmaceutical, biotech, and medical device stocks.
Sector Market Cap
$6.2T
Tracks 1129 stocks · top 50 by market cap
Median YTD Return
+2.1%
Screener universe · median stock return
Median P/E
26.7x
Screener stocks · excludes outliers
Median Dividend Yield
2.03%
Screener stocks · excludes zeros
Loading Performance Chart...
Sector Screener
Rank the Healthcare with daily updated market and fundamental data
Scan the sector leaders, compare valuations and fundamentals, then open the full screener to refine your criteria.
Filter by:
| Ticker | Company | Price | Mkt Cap | P/E | ROE | Div Yield | |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Company | $1235.56 | $1.17T | 53.8 | 101.2% | 0.5% | ||
| Johnson & Johnson | $267.24 | $643.31B | 24.2 | 35% | 1.9% | ||
| AbbVie Inc. | $254.65 | $449.91B | 107.4 | 6214.7% | 2.6% | ||
| UnitedHealth Group Incorporated | $428.19 | $388.86B | 32.4 | 11.8% | 2% | ||
| Merck & Co., Inc. | $128.86 | $318.26B | 17.7 | 36.9% | 2.5% | ||
| Novartis AG | $157.03 | $299.63B | 21.8 | 31% | 2.6% | ||
| AstraZeneca PLC | $193.12 | $299.39B | 29.5 | 22.9% | 1.7% | ||
| Novo Nordisk A/S | $49.64 | $220.59B | 14.1 | 60.7% | 3.6% | ||
| Amgen Inc. | $368.10 | $198.66B | 25.9 | 106.1% | 2.6% | ||
| Thermo Fisher Scientific Inc. | $516.62 | $191.99B | 29.1 | 13.1% | 0.3% | ||
| Gilead Sciences, Inc. | $136.36 | $169.3B | 20.1 | 40.7% | 2.3% | ||
| Abbott Laboratories | $95.84 | $166.94B | 25.8 | 13% | 2.5% | ||
| Intuitive Surgical, Inc. | $427.30 | $151.33B | 54.3 | 16.6% | — | ||
| Danaher Corporation | $194.19 | $137.44B | 38.5 | 7.1% | 0.6% | ||
| Pfizer Inc. | $24.07 | $136.92B | 17.7 | 8.9% | 7.1% | ||
| CVS Health Corporation | $104.33 | $133.12B | 75.1 | 2.3% | 2.6% | ||
| Vertex Pharmaceuticals Incorporated | $522.25 | $132.84B | 34.1 | 22.5% | — | ||
| Stryker Corporation | $313.38 | $120.14B | 37.3 | 15.1% | 1.1% | ||
| Bristol-Myers Squibb Company | $57.97 | $118.36B | 16.8 | 40.4% | 4.3% | ||
| Medtronic plc | $83.83 | $107.63B | 22.5 | 9.8% | 3.4% | ||
| GSK plc | $53.32 | $107.23B | 7.2 | 39.4% | 6.1% | ||
| Sanofi | $42.98 | $103.34B | 11.8 | 10.4% | 5.9% | ||
| McKesson Corporation | $807.33 | $97.04B | 21.0 | — | 0.4% | ||
| HCA Healthcare, Inc. | $423.11 | $93.86B | 14.9 | — | 0.7% | ||
| Elevance Health Inc. | $418.85 | $90.96B | 16.7 | 13.3% | 1.6% | ||
| Cigna Corporation | $286.62 | $75.57B | 12.9 | 14.3% | 2.1% | ||
| Regeneron Pharmaceuticals, Inc. | $676.23 | $70.26B | 16.3 | 14.9% | 0.5% | ||
| Boston Scientific Corporation | $45.30 | $67.33B | 23.4 | 12.4% | — | ||
| Cencora, Inc. | $304.48 | $59.24B | 38.3 | 122.7% | 0.7% | ||
| argenx SE | $919.94 | $56.93B | 46.9 | 20.2% | — |
LLYEli Lilly and Company
$1235.56Price
Mkt Cap$1.17T
P/E53.8
ROE101.2%
Div Yield0.5%
JNJJohnson & Johnson
$267.24Price
Mkt Cap$643.31B
P/E24.2
ROE35%
Div Yield1.9%
ABBVAbbVie Inc.
$254.65Price
Mkt Cap$449.91B
P/E107.4
ROE6214.7%
Div Yield2.6%
UNHUnitedHealth Group Incorporated
$428.19Price
Mkt Cap$388.86B
P/E32.4
ROE11.8%
Div Yield2%
MRKMerck & Co., Inc.
$128.86Price
Mkt Cap$318.26B
P/E17.7
ROE36.9%
Div Yield2.5%
NVSNovartis AG
$157.03Price
Mkt Cap$299.63B
P/E21.8
ROE31%
Div Yield2.6%
AZNAstraZeneca PLC
$193.12Price
Mkt Cap$299.39B
P/E29.5
ROE22.9%
Div Yield1.7%
NVONovo Nordisk A/S
$49.64Price
Mkt Cap$220.59B
P/E14.1
ROE60.7%
Div Yield3.6%
AMGNAmgen Inc.
$368.10Price
Mkt Cap$198.66B
P/E25.9
ROE106.1%
Div Yield2.6%
TMOThermo Fisher Scientific Inc.
$516.62Price
Mkt Cap$191.99B
P/E29.1
ROE13.1%
Div Yield0.3%
GILDGilead Sciences, Inc.
$136.36Price
Mkt Cap$169.3B
P/E20.1
ROE40.7%
Div Yield2.3%
ABTAbbott Laboratories
$95.84Price
Mkt Cap$166.94B
P/E25.8
ROE13%
Div Yield2.5%
ISRGIntuitive Surgical, Inc.
$427.30Price
Mkt Cap$151.33B
P/E54.3
ROE16.6%
Div Yield—
DHRDanaher Corporation
$194.19Price
Mkt Cap$137.44B
P/E38.5
ROE7.1%
Div Yield0.6%
PFEPfizer Inc.
$24.07Price
Mkt Cap$136.92B
P/E17.7
ROE8.9%
Div Yield7.1%
CVSCVS Health Corporation
$104.33Price
Mkt Cap$133.12B
P/E75.1
ROE2.3%
Div Yield2.6%
VRTXVertex Pharmaceuticals Incorporated
$522.25Price
Mkt Cap$132.84B
P/E34.1
ROE22.5%
Div Yield—
SYKStryker Corporation
$313.38Price
Mkt Cap$120.14B
P/E37.3
ROE15.1%
Div Yield1.1%
BMYBristol-Myers Squibb Company
$57.97Price
Mkt Cap$118.36B
P/E16.8
ROE40.4%
Div Yield4.3%
MDTMedtronic plc
$83.83Price
Mkt Cap$107.63B
P/E22.5
ROE9.8%
Div Yield3.4%
GSKGSK plc
$53.32Price
Mkt Cap$107.23B
P/E7.2
ROE39.4%
Div Yield6.1%
SNYSanofi
$42.98Price
Mkt Cap$103.34B
P/E11.8
ROE10.4%
Div Yield5.9%
MCKMcKesson Corporation
$807.33Price
Mkt Cap$97.04B
P/E21.0
ROE—
Div Yield0.4%
HCAHCA Healthcare, Inc.
$423.11Price
Mkt Cap$93.86B
P/E14.9
ROE—
Div Yield0.7%
ELVElevance Health Inc.
$418.85Price
Mkt Cap$90.96B
P/E16.7
ROE13.3%
Div Yield1.6%
CICigna Corporation
$286.62Price
Mkt Cap$75.57B
P/E12.9
ROE14.3%
Div Yield2.1%
REGNRegeneron Pharmaceuticals, Inc.
$676.23Price
Mkt Cap$70.26B
P/E16.3
ROE14.9%
Div Yield0.5%
BSXBoston Scientific Corporation
$45.30Price
Mkt Cap$67.33B
P/E23.4
ROE12.4%
Div Yield—
CORCencora, Inc.
$304.48Price
Mkt Cap$59.24B
P/E38.3
ROE122.7%
Div Yield0.7%
ARGXargenx SE
$919.94Price
Mkt Cap$56.93B
P/E46.9
ROE20.2%
Div Yield—
Sector Outlook
Healthcare Sector Outlook - Q1 2026
Updated Q1 2026
Procedure volumes, GLP-1 demand shifts, and hospital labor normalization are key drivers for providers and devices. Watch drug pricing policy and patent replacement pipelines for large incumbents.
The best opportunities usually come from segment selection, not broad sector timing. Quality compounders and speculative clinical-stage names coexist, so discipline on valuation matters.
Learn
Understanding the Healthcare Sector
What Is the Healthcare Sector?
Healthcare under GICS groups companies tied to medicine, patient care, diagnostics, life sciences, or health insurance — from large pharma and biotech to hospital systems, device makers, and health tech vendors.
Drug makers and insurers are valued on cash flow and pricing power. Biotech and devices are more about pipeline quality and product adoption. XLV gives a large-cap snapshot, but the full sector has a wider range of business models.
How to Invest in Healthcare Stocks
XLV offers broad exposure to established healthcare leaders. Stock selection is more useful for targeted pharma, managed care, device, or biotech exposure.
Key risks: regulation, reimbursement changes, patent cliffs, trial failures, and utilization shifts. In defensive phases, investors favor insurers and large-cap pharma. In risk-on phases, biotech pipelines and high-growth medtech get attention.
Use the screener to separate recurring cash flow businesses from binary-event stories. Margin stability, balance sheet strength, and valuation work best when compared within the right sub-group.
Explore Further
Related Themes & Screens in Healthcare
Frequently Asked Questions
Healthcare includes pharma, biotech, insurers, hospitals, device makers, diagnostics, and life sciences tools. The screener above shows the sector list with sortable data.
Explore More
Other Market Sectors
Dive into other sector analyses with performance tracking, valuation metrics, and industry breakdowns.
Technology Sector Stocks: Performance, Valuations & Industry Comps
XLKScreen and research technology sector stocks with daily updated valuations, performance charts, and pre-filtered metrics for software, semiconductors, and hardware in 2026.
Financial Services Sector Stocks: Performance, Valuations & Industry Comps
XLFScreen and research financial services sector stocks with daily updated valuations, yields, and pre-filtered metrics for banks, insurance, and payments in 2026.
Consumer Cyclical Sector Stocks: Performance, Valuations & Industry Comps
XLYScreen and research consumer cyclical sector stocks with daily updated valuations, margins, and pre-filtered metrics for retail, autos, and restaurants in 2026.
Consumer Defensive Sector Stocks: Performance, Valuations & Industry Comps
XLPScreen and research consumer defensive sector stocks with daily updated valuations, dividend yields, and metrics for food, household goods, and staples retail in 2026.
Energy Sector Stocks: Performance, Valuations & Industry Comps
XLEScreen and research energy sector stocks with daily updated valuations, free cash flows, and metrics for oil, gas, refining, and service companies in 2026.
Basic Materials Sector Stocks: Performance, Valuations & Industry Comps
XLBScreen and research basic materials sector stocks with daily updated valuations, commodity metrics, and pre-filtered metrics for chemicals, metals, and packaging in 2026.
Ready to Build Your Healthcare Portfolio?
Use our powerful screener to filter Healthcare stocks by market cap, valuation, profitability, and dozens of other fundamental metrics.
100+ Metrics
Valuation, growth, profitability, technicals
Daily Updates
Prices, fundamentals, and estimates refreshed overnight
Save & Share
Bookmark custom screens and track over time